The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection

Immunity. 2020 Jun 16;52(6):887-889. doi: 10.1016/j.immuni.2020.04.018. Epub 2020 May 13.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • COVID-19 / complications
  • COVID-19 / therapy
  • COVID-19 / virology
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Pneumonia / etiology
  • Pneumonia / therapy*
  • SARS-CoV-2